This drug is used to promote weight loss in grown-ups who struggle with weight issues and works by reducing appetite and adding the feeling of fullness
Here, we used real-world data to confirm the effects of semaglutide and to complement existing data from prior clinical trials and real-world studies of the broader GLP-1 RA class
Your medical provider will monitor your response and adjust the dosage schedule based on your individual tolerance and results
cohort study, the 2-year discontinuation rate for GLP-1 receptor agonists was 64.1% among people with type 2 diabetes mellitus, driven by factors such as older age, low income, gastrointestinal adverse events, and insufficient weight loss [115]
It has high bioavailability when administered orally or subcutaneously
Participants in this study were at least 66 years old and had type 2 diabetes